The present invention provides a family of binding proteins that bind and neutralize the activity of hepatocyte growth factor (HGF), in particular human HGF. The binding proteins can be used as diagnostic and/or therapeutic agents. With regard to their therapeutic activity, the binding proteins can be used to treat certain HGF responsive disorders, for example, certain HGF responsive tumors.


< Dna Sequence, and Recombinant Preparation of Group 4 Major Allergens From Cereals

> Selective reduction of spinosyn factors Et-J and Et-L to spinetoram

~ 00429